StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.31−0.68 (-17.04%)

Close on Nov 17, 2026Market cap $30.72MP/E –Yield –

Exozymes price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Exozymes's price to book ratio was 10.2× on Nov 11, 2026, against 24.8× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.2×−6.9
2025Dec 31, 202517.0×–

More Exozymes figures

See a number that looks wrong?